|
|
| ACHN-978 / Achaogen (0 Trials) |
|
| ACI-24 / AC Immune (1 Trials) |
|
| ACI-24.060 / Takeda (0 Trials) |
|
| ACI-3024 / AC Immune, Eli Lilly (0 Trials) |
|
| ACI-35 / J&J (0 Trials) |
|
| ACI-7104.056 / AC Immune (1 Trials) |
|
| ACI-91 / Roche (0 Trials) |
|
| aciclovir / Generic mfg. (0 Trials) |
|
| acimtamig (AFM13) / Affimed (2 Trials) |
|
| ACIT-1 / Cancer Vaccines Limited (0 Trials) |
|
| acitretin / Generic mfg. (18 Trials) |
|
| aclarubicin / Generic mfg. (0 Trials) |
|
| aclidinium bromide / Joincare (0 Trials) |
|
| aclimostat (ZGN-1061) / Larimar Therap (0 Trials) |
|
| ACLX-001 / Gilead (0 Trials) |
|
| ACLX-002 / Arcellx (0 Trials) |
|
| ACLX-003 / Arcellx (0 Trials) |
|
| ACM-001 / ACM Biolabs (0 Trials) |
|
| ACM-004 / ACM Biolabs (0 Trials) |
|
| ACM-005 / ACM Biolabs (0 Trials) |
|
| ACmab1 / Axon Neurosci (0 Trials) |
|
| Acoalan (antithrombin gamma) / Kyowa Kirin (1 Trials) |
|
| Acofide (acotiamide) / Zeria Pharma, Astellas (2 Trials) |
|
| acolbifene / Endoceutics (1 Trials) |
|
| Acomplia (rimonabant) / Sanofi (13 Trials) |
|
| acoziborole (SCYX-7158) / SCYNEXIS (2 Trials) |
|
| ACP-01 / Hemostemix, Aspire Health Science (0 Trials) |
|
| ACP-044 / Acadia Pharma (0 Trials) |
|
| ACP-204 / Acadia Pharma (0 Trials) |
|
| ACP-319 / AstraZeneca (2 Trials) |
|
| ACP-711 / Acadia Pharma (0 Trials) |
|
| acriflavine / Johns Hopkins University (0 Trials) |
|
| acrixolimab (YBL-006) / Y-Biologics (0 Trials) |
|
| acrizanib (LHA510) / Novartis (0 Trials) |
|
| ACT 2001 / Alden Cancer Therapy II (1 Trials) |
|
| ACT-02 / Accure Therap (0 Trials) |
|
| ACT-03 / Accure Therap (0 Trials) |
|
| ACT-1004-1239 / Idorsia (0 Trials) |
|
| ACT-1014-6470 / Idorsia (0 Trials) |
|
| ACT-20-CM / NeoProgen, Aspire Health Science (0 Trials) |
|
| ACT-20-MSC / NeoProgen, Aspire Health Science (0 Trials) |
|
| ACT-539313 / Idorsia (0 Trials) |
|
| ACT-901 / Alpha Cancer Technologies, Princess Margaret Cancer Centre (0 Trials) |
|
| ACT-902 / Alpha Cancer Technologies (0 Trials) |
|
| ACT-903 / Alpha Cancer Technologies (0 Trials) |
|
| ACT01 / DRI Biosci (0 Trials) |
|
| Actair (house dust mite allergen desensitization) / Stallergenes, Shionogi (0 Trials) |
|
| ACTallo IMA30x / Editas Medicine, Immatics (0 Trials) |
|
| ACTB1010 / EddingPharm (0 Trials) |
|
| Actelion-2 / J&J (0 Trials) |
|
| Actemra IV (tocilizumab) / Roche, JW Pharma (207 Trials) |
|
| Actemra SC (tocilizumab SC) / Roche, Halozyme (20 Trials) |
|
| ACTEX-M / Avalon GloboCare (0 Trials) |
|
| Actikerall (fluorouracil salicylic acid) / Almirall (0 Trials) |
|
| Actimab-A (lintuzumab-Ac225) / Actinium (4 Trials) |
|
| actimab-B (BC8-Ac-225) / Actinium (0 Trials) |
|
| Actimab-C / Actinium (0 Trials) |
|
| Actimab-P / Actinium (0 Trials) |
|
| Actimmune (interferon gamma-1 b) / Clinigen, Amgen (5 Trials) |
|
| Actinium-225 conjugated to daratumumab / Actinium (0 Trials) |
|
| Actinium-225 DOTATATE (RYZ101) / BMS (0 Trials) |
|
| Actinium-225 PNT6555 / Eli Lilly (0 Trials) |
|
| actinium-225 radio-conjugate theranostic / Actinium, Astellas (0 Trials) |
|
| actinium-225 zalsenertant tetraxetan (225Ac-FPI-2059) / 3B Pharma, AstraZeneca (0 Trials) |
|
| Activase (alteplase) / Roche, Boehringer Ingelheim, Kyowa Kirin, Mitsubishi Tanabe (70 Trials) |
|
| activated CIK and bispecific antibody / Benhealth Biopharma (1 Trials) |
|
| activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody / Benhealth Biopharma (0 Trials) |
|
| activin-like kinase 5 inhibitor / Bausch Health (0 Trials) |
|
| ACTM-838 / Actym Therap (0 Trials) |
|
| Actoferon (IFN beta1b biosimilar) / Actoverco, AMEGA Biotech (0 Trials) |
|
| Actoplus Met XR (pioglitazone/metformin XR) / Takeda (0 Trials) |
|
| Actorif (Interferon β -1a) / Actoverco, AMEGA Biotech (0 Trials) |
|
| Actorise (darbepoetin alfa biosimilar) / Cipla, Hetero (0 Trials) |
|
| Actostim (filgrastim biosimilar) / Actoverco (0 Trials) |
|
| actoxumab/bezlotoxumab (MK-3415A) / Merck (MSD) (0 Trials) |
|
| ACTR087 / Cogent Biosci (0 Trials) |
|
| ACTR707 / Cogent Biosci (0 Trials) |
|
| ACTUS-101 / Bayer (0 Trials) |
|
| acumapimod (BCT-197) / Mereo Biopharma (0 Trials) |
|
| Acute GvHD therapy / ImStem Biotech (0 Trials) |
|
| acute myeloid leukemia therapy / TheraVectys (0 Trials) |
|
| ACvac1 / Axon Neurosci (0 Trials) |
|
| ACVRL1 protein antagonist / Merck (MSD) (0 Trials) |
|
| ACXT-3102 / Accuronix Therap (0 Trials) |
|
| ACY-738 / BMS (0 Trials) |
|
| ACY-957 / Regenacy (0 Trials) |
|
| acyclovir / Generic mfg. (43 Trials) |
|
| acyline (MER-104) / Merrion (1 Trials) |
|
| AD 337 / Sosei (1 Trials) |
|
| AD 4 / Yissum Research Development Company (0 Trials) |
|
| AD-103 / Yuhan Corp (0 Trials) |
|
| AD-104 / Yuhan Corp (0 Trials) |
|
| AD-106 / Yuhan Corp (0 Trials) |
|
| AD-201 / Yuhan Corp (0 Trials) |
|
| AD-203 / Yuhan Corp (0 Trials) |
|
| AD-204 / Yuhan Corp (0 Trials) |
|
| AD-205 / Yuhan Corp (0 Trials) |
|
| AD-206 / Yuhan Corp (0 Trials) |
|
| AD-207 / Yuhan Corp (0 Trials) |
|
| AD-209 / Yuhan Corp (0 Trials) |
|
| AD-210 / Yuhan Corp (0 Trials) |
|
| AD-212 / Yuhan Corp (0 Trials) |
|
| AD-213 / Yuhan Corp (0 Trials) |
|
| AD-2132 / Yuhan Corp (0 Trials) |
|
| AD-214 / AdAlta (0 Trials) |
|
| AD-214 / Yuhan Corp (0 Trials) |
|
| AD-216 / Yuhan Corp (0 Trials) |
|
| AD-217 / Yuhan Corp (0 Trials) |
|
| AD-218 / Yuhan Corp (0 Trials) |
|
| AD-301 / Yuhan Corp (0 Trials) |
|
| AD-35 / Zhejiang Hisun (0 Trials) |
|
| Ad-CCL21-DC / National Cancer Institute (1 Trials) |
|
| Ad-IL24 gene therapy / MultiVir (0 Trials) |
|
| Ad-p53 gene therapy / MultiVir (1 Trials) |
|
| Ad-RTS-hIL-12 / Alaunos Therap (0 Trials) |
|
| Ad-SGE-REIC / Momotaro-Gene (0 Trials) |
|
| Ad-VirRx 007 / MultiVir (0 Trials) |
|
| AD01 / AFFiRiS (0 Trials) |
|
| AD03 / AFFiRiS (0 Trials) |
|
| AD047 / Apnimed (0 Trials) |
|
| AD101 / AmyriAD (0 Trials) |
|
| AD113 / Apnimed (0 Trials) |
|
| AD1502 / BioArctic (0 Trials) |
|
| AD1503 / BioArctic (0 Trials) |
|
| AD17002 / Advagene Biopharma (0 Trials) |
|
| AD1801 / BioArctic, Eisai (0 Trials) |
|
| AD182 / Apnimed (0 Trials) |
|
| Ad26.Mos4.HIV / J&J (0 Trials) |
|
| AD2603 / BioArctic (0 Trials) |
|
| AD275 / Apnimed (0 Trials) |
|
| AD282 / Apnimed (0 Trials) |
|
| AD313 / Apnimed (0 Trials) |
|
| Ad4-Env145NFL / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| Ad4-Env150KN / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| Ad4-EnvC150 HIV vaccine / Emergent Biosolutions (0 Trials) |
|
| Ad4-mGag HIV vaccine / Emergent Biosolutions (0 Trials) |
|
| Ad5 S / Greffex (0 Trials) |
|
| Ad5-Covid-S/N / ImmunityBio (0 Trials) |
|
| Ad5-triCoV/Mac / McMaster University (0 Trials) |
|
| Ad5.F35-hGCC-PADRE vaccine / Liminatus (0 Trials) |
|
| AD504 / Apnimed (0 Trials) |
|
| ad6nsmut HCV vaccine / GSK (0 Trials) |
|
| ADA-011 / Adanate (0 Trials) |
|
| Adacel (tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine adsorbed) / Sanofi (0 Trials) |
|
| adafosbuvir (AL-335) / J&J, Medivir (0 Trials) |
|
| Adagen (pegademase bovine) / Leadiant Biosci (0 Trials) |
|
| Adagio (insulin) / Aerami Therap, Hikma (4 Trials) |
|
| adagloxad simolenin (OBI 822) / OBI Pharma (2 Trials) |
|
| Adakveo (crizanlizumab-tmca) / Novartis (0 Trials) |
|
| adalimumab biobetter (ZB002) / Zenas BioPharma (0 Trials) |
|
| adalimumab biosimilar / LFB SA (0 Trials) |
|
| adalimumab biosimilar / Harvest Moon (0 Trials) |
|
| adalimumab biosimilar / Stada, Insud Pharma (0 Trials) |
|
| adalimumab biosimilar / MabAsia (0 Trials) |
|
| adalimumab biosimilar / NeuClone, Serum Institute of India (0 Trials) |
|
| adalimumab biosimilar / Mycenax (0 Trials) |
|
| adalimumab biosimilar / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| adalimumab biosimilar / Arecor (0 Trials) |
|
| Adalimumab BS MA (adalimumab biosimilar) / Mochida, LG Chem, Daewoong Pharma (0 Trials) |
|
| adapalene / Generic mfg. (12 Trials) |
|
| adapalene/benzoyl peroxide / Generic mfg. (3 Trials) |
|
| adapalene/minocycline (FCD105) / Fortress (0 Trials) |
|
| ADAR1 inhibitor / Exelixis, STORM Therap (0 Trials) |
|
| Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir (2 Trials) |
|
| adavosertib (AZD1775) / AstraZeneca (18 Trials) |
|
| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca (10 Trials) |
|
| ADC-1 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| ADC-1001 / Abzena, Alligator Biosci, Bayer (0 Trials) |
|
| ADC-1004 / Alligator Biosci (0 Trials) |
|
| ADC-1012 / Alligator Biosci (0 Trials) |
|
| ADC-1014 / Alligator Biosci (0 Trials) |
|
| ADC-7405 / Pulmagen Therap (0 Trials) |
|
| ADC-9971 / Pulmagen Therap (0 Trials) |
|
| aDC1 vaccine / Roswell Park, University of Pittsburgh (0 Trials) |
|
| ADC2122 / ZovaBio, Adcoris (0 Trials) |
|
| ADC3277 / Pulmagen Therap (0 Trials) |
|
| ADC8316 / Pulmagen Therap (0 Trials) |
|
| AdCD40L / Uppsala University (0 Trials) |
|
| ADCE-D01 / Adcendo (0 Trials) |
|
| Adcetris (brentuximab vedotin) / Takeda, Pfizer (78 Trials) |
|
| AdCh3NSmut HCV vaccine / GSK (0 Trials) |
|
| Adcitmer / University of Tours (0 Trials) |
|
| Adcitmer (McSAF 03) / McSAF, University of Tours (0 Trials) |
|
| AdCLD-CoV19 / Cellid (0 Trials) |
|
| AdCLD-CoV19-1 OMI / Cellid (0 Trials) |
|
| AdCOVID (COVID-19 vaccine) / Altimmune, The University of Alabama (0 Trials) |
|
| ADCT-212 / ADC Therapeutics (0 Trials) |
|
| ADCT-502 / ADC Therapeutics (0 Trials) |
|
| ADCT-701 / ADC Therapeutics (0 Trials) |
|
| ADCTA immunotherapy / Safe Save Cell (0 Trials) |
|
| ADCV01 / Ever Supreme Bio Tech (0 Trials) |
|
| ADD-OC1 / PharmaLogika (0 Trials) |
|
| ADD422007 / Bio-Pharm Solutions (0 Trials) |
|
| ADD428012 / Bio-Pharm Solutions (0 Trials) |
|
| ADD446019 / Bio-Pharm Solutions (0 Trials) |
|
| ADD447011 / Bio-Pharm Solutions (0 Trials) |
|
| ADD457023 / Bio-Pharm Solutions (0 Trials) |
|
| ADD485002 / Bio-Pharm Solutions (0 Trials) |
|
| ADD532005 / Bio-Pharm Solutions (0 Trials) |
|
| Additional nucleotide inhibhitors / Merck (MSD) (0 Trials) |
|
|